4.6 Article

MEK1/2 inhibitor U0126 but not endothelin receptor antagonist clazosentan reduces upregulation of cerebrovascular contractile receptors and delayed cerebral ischemia, and improves outcome after subarachnoid hemorrhage in rats

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Signal transduction in cerebral arteries after subarachnoid hemorrhage-a phosphoproteomic approach

Benjamin L. Parker et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)

Review Endocrinology & Metabolism

Pharmacologic reduction of angiographic vasospasm in experimental subarachnoid hemorrhage: systematic review and meta-analysis

Tommaso Zoerle et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)

Review Endocrinology & Metabolism

Vascular plasticity in cerebrovascular disorders

Lars I. H. Edvinsson et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)

Article Cardiac & Cardiovascular Systems

Cerebrovascular ETB, 5-HT1B, and AT1 receptor upregulation correlates with reduction in regional CBF after subarachnoid hemorrhage

Saema Ansar et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)

Review Clinical Neurology

Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution

R. Loch Macdonald et al.

NATURE CLINICAL PRACTICE NEUROLOGY (2007)